United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
signifor 0.3mg1ml solution for injection ampoules
novartis pharmaceuticals uk ltd - pasireotide diaspartate - solution for injection - 300microgram/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
signifor 0.6mg1ml solution for injection ampoules
novartis pharmaceuticals uk ltd - pasireotide diaspartate - solution for injection - 600microgram/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
signifor 0.9mg1ml solution for injection ampoules
novartis pharmaceuticals uk ltd - pasireotide diaspartate - solution for injection - 900microgram/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
signifor 20mg powder and solvent for suspension for injection vials
novartis pharmaceuticals uk ltd - pasireotide pamoate - powder and solvent for suspension for injection - 20mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
signifor 40mg powder and solvent for suspension for injection vials
novartis pharmaceuticals uk ltd - pasireotide pamoate - powder and solvent for suspension for injection - 40mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
signifor 60mg powder and solvent for suspension for injection vials
novartis pharmaceuticals uk ltd - pasireotide pamoate - powder and solvent for suspension for injection - 60mg
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
signifor 0.3 mg/1ml solution for injection
fta healthcare sdn. bhd. - pasireotide diaspartate -
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
signifor 0.6 mg/1ml solution for injection
fta healthcare sdn. bhd. - pasireotide diaspartate -
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
signifor 0.9 mg/1ml solution for injection
fta healthcare sdn. bhd. - pasireotide diaspartate -
Israel -
English -
Ministry of Health
signifor lar 20 mg
medison pharma ltd - pasireotide as embonate - powder and solvent for suspension for injection - pasireotide as embonate 20 mg/vial - pasireotide - signifor lar is indicated for the treatment of adult patients with acromegaly for whom surgery is not an option or has not been curative and who are inadequately controlled on treatment with another somatostatin analogue.treatment of adult patients with cushing’s disease for whom surgery is not an option or for whom surgery has failed.